[Home ] [Archive]   [ فارسی ]  
:: Volume 24, Issue 3 (Scientific Journal of Kurdistan University of Medical Sciences 2019) ::
SJKU 2019, 24(3): 121-133 Back to browse issues page
Investigation of the plasma levels of CCL-17 and CCL-25 and their receptor gene expression in rheumatoid arthritis patients
Zahra Samimi1 , Bahareh Kardideh1 , Ahmad Mohammadi-Farani2 , Mostafa Darabinejad3, Mahdi Taghadosi 4
1- Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
2- Pharmaceutical Sciences Research Center, School of Pharmacy, KermanshahUniversity of Medical Sciences, Kermanshah, Iran.
3- Student Research Committee, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
4- Department of Immunology, Kermanshah University of Medical Sciences, Kermanshah, Iran. , mtaghad@gmail.com
Abstract:   (305 Views)
Background and Aim: Rheumatoid arthritis (RA) is an autoimmune inflammatory disease of unknown etiology.  The chemokines and their related receptors have a pivotal role in migration and homing of leukocyte involved in the pathogenesis of RA. The goal of this study was to measure the plasma levels of CCL-17 and CCL-25 and their receptors gene (CCR4 and CCR9) expression in rheumatoid arthritis patients.
Materials and Methods: 30 untreated newly diagnosed and 30 under treatment RA patients with disease modifying anti-rheumatic drugs (DMARDs) as well as 30 healthy subjects participated in this study. We assessed the gene expression of CCR4 and CCR9 by the real-time PCR method, and measured plasma levels of CCL25 and CCL17 by enzyme-linked immunosorbent assay (ELISA).
Results: Comparison between control group and newly diagnosed rheumatoid arthritis patients showed significantly lower expression of CCR4 and CCR9 (P=0.047, P=0.049 respectively) in the latter group. In addition, the plasma level of CCL-25 was significantly lower in both newly diagnosed and under treatment RA patients compared to that in the healthy subjects (P=0.017, P=0.030 respectively).
Conclusion: The altered expression of chemokines and their related receptors, especially those involved in the leukocyte migration to the mucosa of the gastrointestinal tract may be associated with the pathogenesis of RA.
Keywords: Rheumatoid arthritis, Chemokines, Chemokine receptors, DMARD
Full-Text [PDF 293 kb]   (74 Downloads)    
Type of Study: Research | Subject: General
Received: 2019/02/2 | Accepted: 2019/07/7
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Samimi Z, Kardideh B, Mohammadi-Farani A, Darabinejad M, Taghadosi M. Investigation of the plasma levels of CCL-17 and CCL-25 and their receptor gene expression in rheumatoid arthritis patients. SJKU. 2019; 24 (3) :121-133
URL: http://sjku.muk.ac.ir/article-1-4768-en.html


Volume 24, Issue 3 (Scientific Journal of Kurdistan University of Medical Sciences 2019) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی کردستان Scientific Journal of Kurdistan University of Medical Sciences
مجله علمی دانشگاه علوم پزشکی کردستان Scientific Journal of Kurdistan University of Medical Sciences
Persian site map - English site map - Created in 0.06 seconds with 31 queries by YEKTAWEB 3977